CEO SUMMARY: The recent CHS-Labcorp deal is one of many that highlights a market shift. Clinical lab outreach services, once viewed as strategic assets, are being sold off rapidly as hospitals recenter around core services and offload logistical burdens. This year, 30% of lab mergers and acquisitions involve outreach agreements, with national lab companies seeing […]
What’s Behind the Surge in Lab Outreach Sales?
An M&A insider gives her thoughts on why the clinical laboratory market supports such deals
- By Janette Wider
- > From the Volume XXXII, No. 12 - August 25, 2025 Issue
